JPS5859925A - インシユリン分泌増強活性物質及びその製造方法 - Google Patents

インシユリン分泌増強活性物質及びその製造方法

Info

Publication number
JPS5859925A
JPS5859925A JP56159084A JP15908481A JPS5859925A JP S5859925 A JPS5859925 A JP S5859925A JP 56159084 A JP56159084 A JP 56159084A JP 15908481 A JP15908481 A JP 15908481A JP S5859925 A JPS5859925 A JP S5859925A
Authority
JP
Japan
Prior art keywords
column
insulin
insulin secretion
culture
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56159084A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0148919B2 (enrdf_load_stackoverflow
Inventor
Motoyuki Yajima
矢嶋　基之
Makoto Tamura
誠 田村
Katsumi Nogimori
野木森　克巳
Chikanori Tomioka
冨岡　親憲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Kakenyaku Kako KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd, Kakenyaku Kako KK filed Critical Kaken Pharmaceutical Co Ltd
Priority to JP56159084A priority Critical patent/JPS5859925A/ja
Publication of JPS5859925A publication Critical patent/JPS5859925A/ja
Publication of JPH0148919B2 publication Critical patent/JPH0148919B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP56159084A 1981-10-06 1981-10-06 インシユリン分泌増強活性物質及びその製造方法 Granted JPS5859925A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56159084A JPS5859925A (ja) 1981-10-06 1981-10-06 インシユリン分泌増強活性物質及びその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56159084A JPS5859925A (ja) 1981-10-06 1981-10-06 インシユリン分泌増強活性物質及びその製造方法

Publications (2)

Publication Number Publication Date
JPS5859925A true JPS5859925A (ja) 1983-04-09
JPH0148919B2 JPH0148919B2 (enrdf_load_stackoverflow) 1989-10-20

Family

ID=15685873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56159084A Granted JPS5859925A (ja) 1981-10-06 1981-10-06 インシユリン分泌増強活性物質及びその製造方法

Country Status (1)

Country Link
JP (1) JPS5859925A (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017620A1 (en) * 1994-12-04 1996-06-13 Yeda Research And Development Co. Ltd. Pharmaceutical compositions for the treatment of autoimmune diseases comprising the b-oligomer of pertussis toxin or its subunits
US5858965A (en) * 1994-12-04 1999-01-12 Yeda Research And Development Co. Ltd. Pharmaceutical compositions for the treatment of autoimmune diseases comprising the B-oligomer of pertussis toxin or its subunits

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017620A1 (en) * 1994-12-04 1996-06-13 Yeda Research And Development Co. Ltd. Pharmaceutical compositions for the treatment of autoimmune diseases comprising the b-oligomer of pertussis toxin or its subunits
US5858965A (en) * 1994-12-04 1999-01-12 Yeda Research And Development Co. Ltd. Pharmaceutical compositions for the treatment of autoimmune diseases comprising the B-oligomer of pertussis toxin or its subunits

Also Published As

Publication number Publication date
JPH0148919B2 (enrdf_load_stackoverflow) 1989-10-20

Similar Documents

Publication Publication Date Title
Dobner et al. Cloning and sequence analysis of cDNA for the canine neurotensin/neuromedin N precursor.
WO1986004783A1 (en) Neovascularization inhibitors and methods for their production and use
FR2501692A1 (fr) Nouveau produit d'erythropoietine et procede pour sa preparation
CN105233283B (zh) 一种光动力治疗深部肿瘤靶向纳米光敏剂及其制备方法
US4234570A (en) Proteinic active substances
Walker Pharmacological and biochemical properties of a toxin containing material from the jellyfish, Cyanea capillata
KR920002935B1 (ko) 맥관 형성 저해제
JPS5859925A (ja) インシユリン分泌増強活性物質及びその製造方法
WO2018171535A1 (zh) 重组人胰岛素原融合蛋白及其制备方法和用途
US4012502A (en) Snake venom inhibitor material and method of purification
CN112641924B (zh) 一种治疗甲状腺癌的药物及其制备方法和用途
SU871721A3 (ru) Способ получени биологически активного вещества,обладающего способностью усиливать секрецию инсулина и улучшать глюкозную толерантность
JPH07509698A (ja) 後生動物寄生虫に対するワクチン
CN101182529A (zh) 一种融合基因以及基因工程菌及其制备和应用
Maeda et al. Toxicity of bilirubin and detoxification by PEG-bilirubin oxidase conjugate
Wachstein et al. Protective action of certain amino acids on toxicity of mercurial diuretics in rats
Lewis Deantigenated beef blood plasma as a possible substitute for human blood plasma
JPS5946928B2 (ja) 糖尿病治療及び予防薬
CN109276704A (zh) 蜂毒肽在制备治疗和/或预防糖尿病的药物或保健品中的用途
CA2454345A1 (en) Anti-tumor activity from reptile serum
US3919186A (en) Method of recovering cytobiotic globulin from skin tissue
US3936434A (en) Cytobiotic globulins for kidney treatment
JPS6210638B2 (enrdf_load_stackoverflow)
JPS60201259A (ja) 菌型特異的ツベルクリン診断薬
JPH02193984A (ja) 水溶性２―アミノフェノキサジン―３―オンおよびその誘導体の製造方法